Clinical implications of the biology of small cell lung cancer.
Considerable advances have been made over the past 5 years of our understanding of the biology of lung tumours in particular SCLC. In this chapter, and in other sections of this symposium various aspects of these properties have been discussed. The greater understanding of the properties of these tumours should provide means whereby increased success can be achieved in clinical remissions and long term survival for the majority of patients with these diseases.
D000951:Antigens, Neoplasm / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000201:enzymology / Q000473:pathology*; D002460:Cell Line; D003402:Creatine Kinase / Q000032:analysis; D004296:Dopa Decarboxylase / Q000032:analysis; D006801:Humans; D007527:Isoenzymes; D008175:Lung Neoplasms / Q000201:enzymology / Q000473:pathology*; D009857:Oncogenes; D011836:Radiation Tolerance
D000951:Antigens, Neoplasm; D007527:Isoenzymes; D003402:Creatine Kinase; D004296:Dopa Decarboxylase